Uchida K, Yamaguchi H
Research Center for Medical Mycology, Teikyo University.
Jpn J Antibiot. 1994 Oct;47(10):1401-6.
In order to perform a preclinical evaluation of effectiveness of oral terbinafine (TBF) in tinea pedis, an animal model was produced using guinea pigs by experimentally infecting the plantar skin with Trichophyton mentagrophytes. TBF was administered orally to groups of the infected guinea pigs once-a-day for 4 consecutive weeks. The therapeutic efficacy was assessed on the basis of recovery of fungal cultures from the plantar skin. The group of guinea pigs treated with 12.5 mg/kg/day of TBF resulted in complete cure. The animal group treated with 3.13 mg/kg/day of TBF showed significantly better mycological response to the therapy than the group treated with 12.5 mg/kg/day of griseofulvin. These results suggest clinical usefulness of oral TBF for the treatment of tinea pedis.
为了对口服特比萘芬(TBF)治疗足癣的有效性进行临床前评估,使用豚鼠制作了动物模型,通过用须癣毛癣菌实验性感染足底皮肤。将TBF口服给予感染的豚鼠组,每天一次,连续4周。根据从足底皮肤真菌培养物的恢复情况评估治疗效果。用12.5mg/kg/天的TBF治疗的豚鼠组实现了完全治愈。用3.13mg/kg/天的TBF治疗的动物组对治疗的真菌学反应明显优于用12.5mg/kg/天的灰黄霉素治疗的组。这些结果表明口服TBF治疗足癣具有临床实用性。